The Use of Botulinum Toxin in Temporomandibular Disorders: A Bibliometric Study

Year 2023, Volume: 5 Issue: 3, 465 - 71, 18.09.2023

Serkan Yıldız , Feridun Abay , S. Kutalmış Büyük

https://doi.org/10.37990/medr.1287813

Abstract

Aim: Botulinum toxin injections are an important issue that is widely used, and many scientific articles have been published in patients with temporomandibular joint disorders (TMD). The aim of this study was to evaluate the status of activity the use of botulinum toxin in TMD during the period 1978-2023.
Material and Methods: Articles published until April 1, 2023 were searched in Web of Science. The top 50 articles with the highest citations and suitable for the study topic were selected among the totally 299 articles.
Results: Even though the articles published about botulinum injection in TMD have increased in recent years, there is no regular increase over the years. The most cited article was published in 2015 and the number of citations in Web of Science was 194. While there was no difference in productivity among the authors, the most productive country was the United States. Türkiye was found to be above the average among other countries.
Conclusion: This bibliometric study of the top 50 most-cited papers in Web of Science the use of botulinum toxin in TMD recognized a quantitative and qualitative analysis of this very favorable research field.

Keywords

Botulinum toxin, Bibliometrics, Temporomandibular disorders

References

• Gauer RL, Semidey MJ. Diagnosis and treatment of temporomandibular disorders. Am Fam Physician. 2015;91:378-86.
• Sipahi Calis A, Colakoglu Z, Gunbay S. The use of botulinum toxin-a in the treatment of muscular temporomandibular joint disorders. J Stomatol Oral Maxillofac Surg. 2019;120:322-5. Denglehem C, Maes JM, Raoul G, Ferri J. Toxine botulinique de type a: traitement antalgique des dysfonctions de l’appareil manducateur. Rev Stomatol Chir Maxillofac. 2012;113:27-31.
• Awan KH, Patil S, Alamir AWH, et al. Botulinum toxin in the management of myofascial pain associated with temporomandibular dysfunction. J Oral Pathol Med. 2019;48:192-200.
• Jaspers GWC, Pijpe J, Jansma J. The use of botulinum toxin type a in cosmetic facial procedures. Int J Oral Maxillofac Surg. 2011;40:127-33.
• Jankovic J. Botulinum toxin in clinical practice. J Neurol Neurosurg Psychiatry. 2004;75:951-7.
• Coté TR, Mohan AK, Polder JA, et al. Botulinum toxin type a injections: adverse events reported to the us food and drug administration in therapeutic and cosmetic cases. J Am Acad Dermatol. 2005;53:407-15. Delcanho R, Val M, Nardini L, Manfredini D. Botulinum toxin for treating temporomandibular disorders: what is the evidence? J Oral Facial Pain Headache. 2022;36:6-20.
• Tarazona-Alvarez B, Lucas-Dominguez R, Paredes-Gallardo V, et al. A bibliometric analysis of scientific production in the field of lingual orthodontics. Head Face Med. 2019;15:1-10.
• Jacimovic J, Jakovljevic A, Nagendrababu V, et al. A bibliometric analysis of the dental scientific literature on covid-19. Clin Oral Investig. 2021;25:6171-83.
• Paschoal MAB, Belém FV, Clementino LC, Martins PA. Application of lasers in dentistry: a bibliometric study of the top 100 most-cited papers. Braz Oral Res. 2022;36:e104.
• Balel Y. Bibliometric analysis of international publication trends in impacted third molar surgery research (2000-2020). Br J Oral Maxillofac Surg. 2021;59:1220-6. Monroy PG, da Fonseca MA. The use of botulinum toxin-a in the treatment of severe bruxism in a patient with autism: a case report. Spec Care in Dentist. 2006;26:37-9.